FO
AEGR

FT Options’s Aegerion Pharmaceuticals AEGR Stock Holding History

FT Options’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-16,345
Closed -$37.4K – 447
2016
Q1 		$60K Sell
16,345
-42,100
-72% -$261K 0.06% 153
2015
Q4 		$590K Buy
+58,445
New +$703K 0.44% 57

FT Options's AEGR Position: Q2 2016 in Review

FT Options sold out of Aegerion Pharmaceuticals (AEGR) in Q2 2016, closing a stake of 16,345 shares — an estimated $37.4K sold.

FT Options first reported a position in AEGR in Q4 2015 and held it in 2 quarters. The position peaked at $590K in Q4 2015. 71 funds tracked by Wall St. Rank hold AEGR as of Q2 2016.

  • FT Options reported no remaining Aegerion Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • FT Options sold 16,345 Aegerion Pharmaceuticals shares in Q2 2016, an estimated $37.4K.
  • FT Options first reported a position in Aegerion Pharmaceuticals in Q4 2015 and held it in 2 quarters.
  • FT Options's Aegerion Pharmaceuticals position peaked at $590K in Q4 2015.
  • 71 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q2 2016.

Based on FT Options's 13F filing for Q2 2016, filed 12 Aug 2016.